iFR Assessment of Intermediate Aortic Stenosis Lesions Consolidates

Once a big void that prevented us from effectively assessing functional compromise, intermediate aortic stenosis has made us treat many lesions “just in case”, to save us what would be a complicated procedure, had a valve been placed. Auspiciously, some light has been shed by several, most welcome, studies simultaneously published in J Am Coll Cardiol Intv.

iFR en lesiones no culpables: el momento de la medición parece cambiar la historiaThis study looked at 95 consecutive patients with severe aortic stenosis and intermediate coronary lesions in 116 vessels. It compared invasive iFR with FFR values and non-invasive adenosine stress myocardial perfusion imaging.  

 

Mean iFR was 0.86 (0.76 to 0.93) and FFR was 0.84 (0.76 to 0.91). According to authors, iFR values showed good correlation with FFR values. However, these figures have different clinical implications, seeing as they have different cutoff values. The authors adjusted iFR cut off value to 0.82, but considered standard an FFR cutoff value of ≤0.75. The latter used to be the original value, the one in the DEFER study, one that has been replaced by 0.8 since the FAME trials.


Read also: Safety of Lesion Deferral with iFR or FFR in Both Stable and Acute Patients.


FFR and iFR values also correlated well with perfusion values.

 

Conclusion

According to this study, iFR, FFR, and stress adenosine prefusion values correlate well in patients with severe aortic stenosis. However, this could be misleading: there was no assessment after procedure to check whether values had changed. In this context, rather than changing cutoff index values, it would be easier to measure with iFR alone, since it is not affected by stenosis, compared to FFR which tends to underestimate severity.

 

Original title: Instantaneous Wave-Free Ratio for the Assessment of Intermediate Coronary Artery Stenosis in Patients with Severe Aortic Valve Stenosis. Comparison With Myocardial Perfusion Scintigraphy.

Reference: Futoshi Yamanaka et al.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...